  As the development of a dengue vaccine is ongoing, we simulate an
hypothetical vaccine as an extra protection to the population. In a first
phase, the vaccination process is studied as a new compartment in the model,
and different ways of distributing the vaccines investigated: pediatric and
random mass vaccines, with distinct levels of efficacy and durability. In a
second step, the vaccination is seen as a control variable in the
epidemiological process. In both cases, epidemic and endemic scenarios are
included in order to analyze distinct outbreak realities.
